nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethotoin—Glutethimide—CYP11A1—uterine cancer	0.0801	1	CrCbGaD
Ethotoin—Lymphadenopathy—Progesterone—uterine cancer	0.032	0.0434	CcSEcCtD
Ethotoin—Diplopia—Progesterone—uterine cancer	0.0273	0.037	CcSEcCtD
Ethotoin—Ataxia—Medroxyprogesterone Acetate—uterine cancer	0.0233	0.0316	CcSEcCtD
Ethotoin—Numbness—Etoposide—uterine cancer	0.0232	0.0315	CcSEcCtD
Ethotoin—Sensory loss—Etoposide—uterine cancer	0.0222	0.0301	CcSEcCtD
Ethotoin—Body temperature increased—Carboplatin—uterine cancer	0.0202	0.0274	CcSEcCtD
Ethotoin—Erythema multiforme—Progesterone—uterine cancer	0.0179	0.0242	CcSEcCtD
Ethotoin—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.0162	0.022	CcSEcCtD
Ethotoin—Nystagmus—Epirubicin—uterine cancer	0.0151	0.0205	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.0147	0.02	CcSEcCtD
Ethotoin—Chest pain—Progesterone—uterine cancer	0.014	0.019	CcSEcCtD
Ethotoin—Nystagmus—Doxorubicin—uterine cancer	0.014	0.019	CcSEcCtD
Ethotoin—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.0127	0.0172	CcSEcCtD
Ethotoin—Erythema multiforme—Dactinomycin—uterine cancer	0.0126	0.0171	CcSEcCtD
Ethotoin—Insomnia—Progesterone—uterine cancer	0.0121	0.0165	CcSEcCtD
Ethotoin—Fatigue—Progesterone—uterine cancer	0.0116	0.0157	CcSEcCtD
Ethotoin—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.011	0.0149	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.0107	0.0145	CcSEcCtD
Ethotoin—Body temperature increased—Progesterone—uterine cancer	0.0106	0.0144	CcSEcCtD
Ethotoin—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.0105	0.0142	CcSEcCtD
Ethotoin—Asthenia—Progesterone—uterine cancer	0.00963	0.0131	CcSEcCtD
Ethotoin—Hypoaesthesia—Etoposide—uterine cancer	0.00961	0.013	CcSEcCtD
Ethotoin—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00961	0.013	CcSEcCtD
Ethotoin—Diarrhoea—Progesterone—uterine cancer	0.00918	0.0125	CcSEcCtD
Ethotoin—Lymphadenopathy—Epirubicin—uterine cancer	0.00918	0.0125	CcSEcCtD
Ethotoin—Erythema multiforme—Etoposide—uterine cancer	0.00914	0.0124	CcSEcCtD
Ethotoin—Dizziness—Progesterone—uterine cancer	0.00887	0.012	CcSEcCtD
Ethotoin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00873	0.0118	CcSEcCtD
Ethotoin—Vomiting—Progesterone—uterine cancer	0.00853	0.0116	CcSEcCtD
Ethotoin—Lymphadenopathy—Doxorubicin—uterine cancer	0.00849	0.0115	CcSEcCtD
Ethotoin—Rash—Progesterone—uterine cancer	0.00846	0.0115	CcSEcCtD
Ethotoin—Dermatitis—Progesterone—uterine cancer	0.00845	0.0115	CcSEcCtD
Ethotoin—Headache—Progesterone—uterine cancer	0.00841	0.0114	CcSEcCtD
Ethotoin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00832	0.0113	CcSEcCtD
Ethotoin—Fatigue—Dactinomycin—uterine cancer	0.00818	0.0111	CcSEcCtD
Ethotoin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00804	0.0109	CcSEcCtD
Ethotoin—Nausea—Progesterone—uterine cancer	0.00797	0.0108	CcSEcCtD
Ethotoin—Diplopia—Epirubicin—uterine cancer	0.00783	0.0106	CcSEcCtD
Ethotoin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00773	0.0105	CcSEcCtD
Ethotoin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00767	0.0104	CcSEcCtD
Ethotoin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00766	0.0104	CcSEcCtD
Ethotoin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00762	0.0103	CcSEcCtD
Ethotoin—Body temperature increased—Dactinomycin—uterine cancer	0.0075	0.0102	CcSEcCtD
Ethotoin—Ataxia—Epirubicin—uterine cancer	0.00736	0.00999	CcSEcCtD
Ethotoin—Diplopia—Doxorubicin—uterine cancer	0.00724	0.00983	CcSEcCtD
Ethotoin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00722	0.0098	CcSEcCtD
Ethotoin—Chest pain—Etoposide—uterine cancer	0.00716	0.00972	CcSEcCtD
Ethotoin—Ataxia—Doxorubicin—uterine cancer	0.00681	0.00924	CcSEcCtD
Ethotoin—Asthenia—Dactinomycin—uterine cancer	0.00681	0.00923	CcSEcCtD
Ethotoin—Diarrhoea—Dactinomycin—uterine cancer	0.00649	0.00881	CcSEcCtD
Ethotoin—SCN7A—Axon guidance—PLXNA3—uterine cancer	0.00619	0.0339	CbGpPWpGaD
Ethotoin—Vomiting—Dactinomycin—uterine cancer	0.00603	0.00818	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.00598	0.00812	CcSEcCtD
Ethotoin—Rash—Dactinomycin—uterine cancer	0.00598	0.00811	CcSEcCtD
Ethotoin—Fatigue—Etoposide—uterine cancer	0.00592	0.00803	CcSEcCtD
Ethotoin—SCN5A—Cardiac Progenitor Differentiation—INHBA—uterine cancer	0.00569	0.0311	CbGpPWpGaD
Ethotoin—Nausea—Dactinomycin—uterine cancer	0.00563	0.00764	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00554	0.00751	CcSEcCtD
Ethotoin—SCN11A—Axon guidance—PLXNA3—uterine cancer	0.00552	0.0302	CbGpPWpGaD
Ethotoin—Body temperature increased—Etoposide—uterine cancer	0.00543	0.00736	CcSEcCtD
Ethotoin—Hypoaesthesia—Epirubicin—uterine cancer	0.00539	0.00731	CcSEcCtD
Ethotoin—Erythema multiforme—Epirubicin—uterine cancer	0.00512	0.00695	CcSEcCtD
Ethotoin—SCN8A—Axon guidance—PLXNA3—uterine cancer	0.00505	0.0276	CbGpPWpGaD
Ethotoin—Hypoaesthesia—Doxorubicin—uterine cancer	0.00499	0.00677	CcSEcCtD
Ethotoin—Asthenia—Etoposide—uterine cancer	0.00493	0.00668	CcSEcCtD
Ethotoin—Erythema multiforme—Doxorubicin—uterine cancer	0.00474	0.00643	CcSEcCtD
Ethotoin—Diarrhoea—Etoposide—uterine cancer	0.0047	0.00637	CcSEcCtD
Ethotoin—Dizziness—Etoposide—uterine cancer	0.00454	0.00616	CcSEcCtD
Ethotoin—SCN7A—Developmental Biology—PLXNA3—uterine cancer	0.00442	0.0242	CbGpPWpGaD
Ethotoin—Vomiting—Etoposide—uterine cancer	0.00437	0.00592	CcSEcCtD
Ethotoin—Rash—Etoposide—uterine cancer	0.00433	0.00587	CcSEcCtD
Ethotoin—Dermatitis—Etoposide—uterine cancer	0.00432	0.00587	CcSEcCtD
Ethotoin—Headache—Etoposide—uterine cancer	0.0043	0.00584	CcSEcCtD
Ethotoin—SCN9A—Axon guidance—PLXNA3—uterine cancer	0.00408	0.0223	CbGpPWpGaD
Ethotoin—Nausea—Etoposide—uterine cancer	0.00408	0.00553	CcSEcCtD
Ethotoin—Chest pain—Epirubicin—uterine cancer	0.00401	0.00545	CcSEcCtD
Ethotoin—SCN11A—Developmental Biology—PLXNA3—uterine cancer	0.00394	0.0215	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—PLXNA3—uterine cancer	0.00391	0.0214	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—PLXNA3—uterine cancer	0.00375	0.0205	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—PLXNA3—uterine cancer	0.00375	0.0205	CbGpPWpGaD
Ethotoin—Chest pain—Doxorubicin—uterine cancer	0.00371	0.00504	CcSEcCtD
Ethotoin—SCN10A—Axon guidance—PLXNA3—uterine cancer	0.00362	0.0198	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—PLXNA3—uterine cancer	0.00362	0.0198	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—PLXNA3—uterine cancer	0.0036	0.0197	CbGpPWpGaD
Ethotoin—Insomnia—Epirubicin—uterine cancer	0.00348	0.00472	CcSEcCtD
Ethotoin—Fatigue—Epirubicin—uterine cancer	0.00332	0.0045	CcSEcCtD
Ethotoin—Insomnia—Doxorubicin—uterine cancer	0.00322	0.00437	CcSEcCtD
Ethotoin—Fatigue—Doxorubicin—uterine cancer	0.00307	0.00417	CcSEcCtD
Ethotoin—Body temperature increased—Epirubicin—uterine cancer	0.00304	0.00413	CcSEcCtD
Ethotoin—SCN9A—Developmental Biology—PLXNA3—uterine cancer	0.00291	0.0159	CbGpPWpGaD
Ethotoin—Body temperature increased—Doxorubicin—uterine cancer	0.00281	0.00382	CcSEcCtD
Ethotoin—SCN3A—Developmental Biology—PLXNA3—uterine cancer	0.00279	0.0152	CbGpPWpGaD
Ethotoin—Asthenia—Epirubicin—uterine cancer	0.00276	0.00375	CcSEcCtD
Ethotoin—SCN2A—Developmental Biology—PLXNA3—uterine cancer	0.00268	0.0146	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—PLXNA3—uterine cancer	0.00268	0.0146	CbGpPWpGaD
Ethotoin—Diarrhoea—Epirubicin—uterine cancer	0.00263	0.00357	CcSEcCtD
Ethotoin—SCN1A—Developmental Biology—PLXNA3—uterine cancer	0.00258	0.0141	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—PLXNA3—uterine cancer	0.00258	0.0141	CbGpPWpGaD
Ethotoin—Asthenia—Doxorubicin—uterine cancer	0.00255	0.00347	CcSEcCtD
Ethotoin—Dizziness—Epirubicin—uterine cancer	0.00254	0.00345	CcSEcCtD
Ethotoin—SCN5A—Axon guidance—PLXNA3—uterine cancer	0.00254	0.0139	CbGpPWpGaD
Ethotoin—Vomiting—Epirubicin—uterine cancer	0.00245	0.00332	CcSEcCtD
Ethotoin—Diarrhoea—Doxorubicin—uterine cancer	0.00244	0.00331	CcSEcCtD
Ethotoin—Rash—Epirubicin—uterine cancer	0.00243	0.00329	CcSEcCtD
Ethotoin—Dermatitis—Epirubicin—uterine cancer	0.00242	0.00329	CcSEcCtD
Ethotoin—Headache—Epirubicin—uterine cancer	0.00241	0.00327	CcSEcCtD
Ethotoin—Dizziness—Doxorubicin—uterine cancer	0.00235	0.00319	CcSEcCtD
Ethotoin—SCN7A—Developmental Biology—HNF1B—uterine cancer	0.00232	0.0127	CbGpPWpGaD
Ethotoin—Nausea—Epirubicin—uterine cancer	0.00229	0.0031	CcSEcCtD
Ethotoin—Vomiting—Doxorubicin—uterine cancer	0.00226	0.00307	CcSEcCtD
Ethotoin—Rash—Doxorubicin—uterine cancer	0.00225	0.00305	CcSEcCtD
Ethotoin—Dermatitis—Doxorubicin—uterine cancer	0.00224	0.00304	CcSEcCtD
Ethotoin—Headache—Doxorubicin—uterine cancer	0.00223	0.00303	CcSEcCtD
Ethotoin—Nausea—Doxorubicin—uterine cancer	0.00212	0.00287	CcSEcCtD
Ethotoin—SCN11A—Developmental Biology—HNF1B—uterine cancer	0.00207	0.0113	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—HNF1B—uterine cancer	0.00189	0.0104	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—PLXNA3—uterine cancer	0.00182	0.00993	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—YWHAE—uterine cancer	0.00154	0.00845	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—HNF1B—uterine cancer	0.00153	0.00837	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—HNF1B—uterine cancer	0.00146	0.00801	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—ESR2—uterine cancer	0.00143	0.0078	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—HNF1B—uterine cancer	0.00141	0.00769	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—HNF1B—uterine cancer	0.00141	0.00769	CbGpPWpGaD
Ethotoin—CYP2C19—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.0014	0.00765	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—HNF1B—uterine cancer	0.00136	0.00742	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—HNF1B—uterine cancer	0.00136	0.00742	CbGpPWpGaD
Ethotoin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.00128	0.007	CbGpPWpGaD
Ethotoin—CYP2C19—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.00126	0.00691	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—MET—uterine cancer	0.00118	0.00644	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—MET—uterine cancer	0.00105	0.00574	CbGpPWpGaD
Ethotoin—CYP2C19—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.00104	0.00567	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—SMAD3—uterine cancer	0.00103	0.00561	CbGpPWpGaD
Ethotoin—CYP2C19—Metapathway biotransformation—AKR1B10—uterine cancer	0.000977	0.00534	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—MET—uterine cancer	0.00096	0.00525	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—HNF1B—uterine cancer	0.000953	0.00521	CbGpPWpGaD
Ethotoin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000941	0.00515	CbGpPWpGaD
Ethotoin—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000929	0.00508	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—SMAD3—uterine cancer	0.000914	0.005	CbGpPWpGaD
Ethotoin—CYP2C19—Metapathway biotransformation—AKR1B1—uterine cancer	0.000908	0.00497	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—ERBB2—uterine cancer	0.000861	0.00471	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—MET—uterine cancer	0.000841	0.0046	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—SMAD3—uterine cancer	0.000836	0.00457	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—MET—uterine cancer	0.000777	0.00425	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—ERBB2—uterine cancer	0.000768	0.0042	CbGpPWpGaD
Ethotoin—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000763	0.00417	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—MET—uterine cancer	0.000749	0.0041	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—MET—uterine cancer	0.000743	0.00406	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—MET—uterine cancer	0.000714	0.0039	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—MET—uterine cancer	0.000714	0.0039	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—ERBB2—uterine cancer	0.000702	0.00384	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—MET—uterine cancer	0.000688	0.00376	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—MET—uterine cancer	0.000688	0.00376	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—MET—uterine cancer	0.000685	0.00375	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—SMAD3—uterine cancer	0.000676	0.0037	CbGpPWpGaD
Ethotoin—CYP2C19—Metapathway biotransformation—AKR1C1—uterine cancer	0.000667	0.00365	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—VEGFA—uterine cancer	0.000663	0.00363	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—NRAS—uterine cancer	0.000655	0.00358	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—SMAD3—uterine cancer	0.000647	0.00354	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—SMAD3—uterine cancer	0.000622	0.0034	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—SMAD3—uterine cancer	0.000622	0.0034	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—ERBB2—uterine cancer	0.000615	0.00336	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—CXCL8—uterine cancer	0.000602	0.00329	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—SMAD3—uterine cancer	0.000599	0.00328	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—SMAD3—uterine cancer	0.000599	0.00328	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—VEGFA—uterine cancer	0.000591	0.00323	CbGpPWpGaD
Ethotoin—CYP2C19—Metapathway biotransformation—GPX3—uterine cancer	0.000585	0.0032	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—NRAS—uterine cancer	0.000584	0.00319	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—ERBB2—uterine cancer	0.000568	0.00311	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—KRAS—uterine cancer	0.000564	0.00308	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	0.000555	0.00304	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—MET—uterine cancer	0.000554	0.00303	CbGpPWpGaD
Ethotoin—CYP2C19—Biological oxidations—CYP11A1—uterine cancer	0.000551	0.00301	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—ERBB2—uterine cancer	0.000548	0.003	CbGpPWpGaD
Ethotoin—CYP2C19—Metapathway biotransformation—CYP11A1—uterine cancer	0.000543	0.00297	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—ERBB2—uterine cancer	0.000543	0.00297	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—VEGFA—uterine cancer	0.000541	0.00296	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—CTNNB1—uterine cancer	0.000538	0.00294	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—NRAS—uterine cancer	0.000534	0.00292	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—MET—uterine cancer	0.00053	0.0029	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—ERBB2—uterine cancer	0.000522	0.00285	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—ERBB2—uterine cancer	0.000522	0.00285	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—EP300—uterine cancer	0.000516	0.00282	CbGpPWpGaD
Ethotoin—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	0.000513	0.00281	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—MET—uterine cancer	0.000509	0.00279	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—MET—uterine cancer	0.000509	0.00279	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—ERBB2—uterine cancer	0.000503	0.00275	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—ERBB2—uterine cancer	0.000503	0.00275	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—KRAS—uterine cancer	0.000503	0.00275	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—ERBB2—uterine cancer	0.000501	0.00274	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—EP300—uterine cancer	0.0005	0.00273	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—MET—uterine cancer	0.000491	0.00269	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—MET—uterine cancer	0.000491	0.00269	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000489	0.00268	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—VEGFA—uterine cancer	0.000489	0.00267	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—MET—uterine cancer	0.000484	0.00265	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—HRAS—uterine cancer	0.000479	0.00262	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—CTNNB1—uterine cancer	0.000479	0.00262	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—VEGFA—uterine cancer	0.000473	0.00259	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—NRAS—uterine cancer	0.000468	0.00256	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—KRAS—uterine cancer	0.00046	0.00251	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—EP300—uterine cancer	0.000445	0.00244	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—CTNNB1—uterine cancer	0.000438	0.0024	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—VEGFA—uterine cancer	0.000437	0.00239	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—NRAS—uterine cancer	0.000432	0.00236	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—HRAS—uterine cancer	0.000427	0.00234	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—VEGFA—uterine cancer	0.000422	0.00231	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—SMAD3—uterine cancer	0.000421	0.0023	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—VEGFA—uterine cancer	0.000418	0.00229	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—NRAS—uterine cancer	0.000417	0.00228	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—NRAS—uterine cancer	0.000413	0.00226	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—EP300—uterine cancer	0.000407	0.00223	CbGpPWpGaD
Ethotoin—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	0.000405	0.00222	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—ERBB2—uterine cancer	0.000405	0.00222	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—KRAS—uterine cancer	0.000402	0.0022	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—VEGFA—uterine cancer	0.000402	0.0022	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—VEGFA—uterine cancer	0.000402	0.0022	CbGpPWpGaD
Ethotoin—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	0.0004	0.00219	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—NRAS—uterine cancer	0.000397	0.00217	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—NRAS—uterine cancer	0.000397	0.00217	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—HRAS—uterine cancer	0.000391	0.00214	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—ERBB2—uterine cancer	0.000388	0.00212	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—VEGFA—uterine cancer	0.000388	0.00212	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—VEGFA—uterine cancer	0.000388	0.00212	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—VEGFA—uterine cancer	0.000386	0.00211	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—NRAS—uterine cancer	0.000383	0.00209	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—NRAS—uterine cancer	0.000383	0.00209	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—NRAS—uterine cancer	0.000381	0.00208	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—ERBB2—uterine cancer	0.000372	0.00204	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—ERBB2—uterine cancer	0.000372	0.00204	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—KRAS—uterine cancer	0.000372	0.00203	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—ERBB2—uterine cancer	0.000359	0.00196	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—ERBB2—uterine cancer	0.000359	0.00196	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—KRAS—uterine cancer	0.000359	0.00196	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—KRAS—uterine cancer	0.000356	0.00194	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—CTNNB1—uterine cancer	0.000354	0.00194	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—ERBB2—uterine cancer	0.000354	0.00193	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000354	0.00193	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000354	0.00193	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—MET—uterine cancer	0.000345	0.00189	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—HRAS—uterine cancer	0.000342	0.00187	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—KRAS—uterine cancer	0.000342	0.00187	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—KRAS—uterine cancer	0.000342	0.00187	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—CTNNB1—uterine cancer	0.000339	0.00185	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—EP300—uterine cancer	0.000329	0.0018	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—KRAS—uterine cancer	0.000329	0.0018	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—KRAS—uterine cancer	0.000329	0.0018	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—KRAS—uterine cancer	0.000328	0.00179	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—CTNNB1—uterine cancer	0.000326	0.00178	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—CTNNB1—uterine cancer	0.000326	0.00178	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—HRAS—uterine cancer	0.000316	0.00173	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—EP300—uterine cancer	0.000315	0.00172	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—CTNNB1—uterine cancer	0.000314	0.00172	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—CTNNB1—uterine cancer	0.000314	0.00172	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—VEGFA—uterine cancer	0.000312	0.00171	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—NRAS—uterine cancer	0.000308	0.00169	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—HRAS—uterine cancer	0.000305	0.00167	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—EP300—uterine cancer	0.000303	0.00166	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—EP300—uterine cancer	0.000303	0.00166	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—HRAS—uterine cancer	0.000302	0.00165	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—AKT1—uterine cancer	0.000302	0.00165	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—VEGFA—uterine cancer	0.000298	0.00163	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—NRAS—uterine cancer	0.000295	0.00161	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—EP300—uterine cancer	0.000292	0.0016	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—EP300—uterine cancer	0.000292	0.0016	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—HRAS—uterine cancer	0.00029	0.00159	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—HRAS—uterine cancer	0.00029	0.00159	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—VEGFA—uterine cancer	0.000287	0.00157	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—VEGFA—uterine cancer	0.000287	0.00157	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—NRAS—uterine cancer	0.000283	0.00155	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—NRAS—uterine cancer	0.000283	0.00155	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—HRAS—uterine cancer	0.00028	0.00153	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—HRAS—uterine cancer	0.00028	0.00153	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—HRAS—uterine cancer	0.000279	0.00153	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—VEGFA—uterine cancer	0.000277	0.00151	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—VEGFA—uterine cancer	0.000277	0.00151	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—NRAS—uterine cancer	0.000273	0.00149	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—NRAS—uterine cancer	0.000273	0.00149	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—VEGFA—uterine cancer	0.000272	0.00149	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—AKT1—uterine cancer	0.000269	0.00147	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—NRAS—uterine cancer	0.000269	0.00147	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—KRAS—uterine cancer	0.000265	0.00145	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.00026	0.00142	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—KRAS—uterine cancer	0.000254	0.00139	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—ERBB2—uterine cancer	0.000252	0.00138	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—AKT1—uterine cancer	0.000246	0.00135	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—KRAS—uterine cancer	0.000244	0.00133	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—KRAS—uterine cancer	0.000244	0.00133	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—KRAS—uterine cancer	0.000235	0.00129	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—KRAS—uterine cancer	0.000235	0.00129	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—KRAS—uterine cancer	0.000232	0.00127	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—HRAS—uterine cancer	0.000226	0.00123	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—CTNNB1—uterine cancer	0.000221	0.00121	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—NDUFB11—uterine cancer	0.000218	0.00119	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—SRD5A2—uterine cancer	0.000218	0.00119	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—HRAS—uterine cancer	0.000216	0.00118	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000212	0.00116	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—HRAS—uterine cancer	0.000207	0.00113	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—HRAS—uterine cancer	0.000207	0.00113	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—EP300—uterine cancer	0.000205	0.00112	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.0002	0.00109	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—HRAS—uterine cancer	0.0002	0.00109	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—HRAS—uterine cancer	0.0002	0.00109	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—AKT1—uterine cancer	0.000199	0.00109	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—HRAS—uterine cancer	0.000197	0.00108	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—VEGFA—uterine cancer	0.000194	0.00106	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—NRAS—uterine cancer	0.000192	0.00105	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—AKT1—uterine cancer	0.00019	0.00104	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—AKT1—uterine cancer	0.000183	0.001	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—AKT1—uterine cancer	0.000183	0.001	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—AKT1—uterine cancer	0.000176	0.000965	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—AKT1—uterine cancer	0.000176	0.000965	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—KRAS—uterine cancer	0.000165	0.000904	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—STAR—uterine cancer	0.000158	0.000861	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—AKR1B1—uterine cancer	0.000158	0.000861	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000156	0.000851	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—HRAS—uterine cancer	0.00014	0.000768	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—AKT1—uterine cancer	0.000124	0.000678	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—POLD1—uterine cancer	0.000124	0.000676	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—AKR1C1—uterine cancer	0.000116	0.000632	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—RRM2—uterine cancer	0.000103	0.000564	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—DCN—uterine cancer	0.0001	0.000547	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CYP11A1—uterine cancer	9.42e-05	0.000515	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—AKR1C3—uterine cancer	8.9e-05	0.000487	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—STK11—uterine cancer	6.93e-05	0.000379	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CYP19A1—uterine cancer	6.93e-05	0.000379	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.51e-05	0.000356	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.21e-05	0.000339	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—MTHFR—uterine cancer	5.21e-05	0.000285	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.59e-05	0.000251	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PTEN—uterine cancer	2.9e-05	0.000159	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—EP300—uterine cancer	2.76e-05	0.000151	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PIK3CA—uterine cancer	2.04e-05	0.000112	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—AKT1—uterine cancer	1.67e-05	9.14e-05	CbGpPWpGaD
